English

Apollo Medical Holdings, Inc.

EDGAR

AMEH Quarterly report (10-Q) · filed 2026-08-10

Annual consolidated revenue for 2025: about USD 3.182B, using the latest reported figures. The previous period, 2024, was about USD 2.035B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

973 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 972520000 USD Source

Operating margin

3.53%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 34322000 USD Source
Revenue: 972520000 USD Source

Operating cash flow

32.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 100804000 USD Source
Operating Cash Flow: 68056000 USD Source

Free cash flow

28.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 100804000 USD Source
Operating Cash Flow: 68056000 USD Source
Capital Expenditure: 7878000 USD Source
Capital Expenditure: 4000000 USD Source

Cash and cash equivalents: 401 million USD 2026-06-30 Source
Exact value

400792000 USD
Long-term debt including current maturities: 226 million USD 2020-09-30 Source
Exact value

226051000 USD
Shares outstanding: 48.9 million shares 2025-12-31 Source
Exact value

48885358 shares

Reported share-count change

1.99% · 955 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

47929872 shares · 2024-12-31· Source
48885358 shares · 2025-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.84 billion USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 956048000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 3181769000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 2231243000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 965100000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 972520000 USD · 2026-04-01 – 2026-06-30 Source

Net income

40.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 373000 USD · 2025-07-01 – 2025-09-30 Source
Net income: 22487000 USD · 2025-01-01 – 2025-12-31 Source
Net income: 16488000 USD · 2025-01-01 – 2025-09-30 Source
Net income: 14436000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 19739000 USD · 2026-04-01 – 2026-06-30 Source

Capital expenditure

13.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 7042000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 4490000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 10106000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 7042000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 4000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 7878000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 4000000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-10.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2019-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+56.4%

Prior period

USD 2.03 billion

2024-01-01 – 2024-12-31
Current period

USD 3.18 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

3181769000 − 2034540000 = 1147229000 USD

2034540000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
3181769000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Year-over-year change in Revenue: 1147229000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3181769000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#5394851 Filing: 000119312526103128 Input fundies:Revenue: 2034540000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#5531962 Filing: 000119312526103128
The citation records this snapshot. The page link may show a newer release later.
Net income
-47.9%

Prior period

USD 43.15 million

2024-01-01 – 2024-12-31
Current period

USD 22.49 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

22487000 − 43149000 = -20662000 USD

43149000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
22487000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Year-over-year change in Net income: -20662000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 22487000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2058011 Filing: 000119312526103128 Input fundies:NetIncome: 43149000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2059840 Filing: 000119312526103128
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+119.5%

Prior period

USD 52.2 million

2024-01-01 – 2024-12-31
Current period

USD 114.6 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

114597000 − 52198000 = 62399000 USD

52198000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
114597000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Year-over-year change in Operating cash flow: 62399000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 114597000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2707893 Filing: 000119312526103128 Input fundies:OperatingCashFlow: 52198000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2709735 Filing: 000119312526103128
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+25.8%

Prior period

USD 8.03 million

2024-01-01 – 2024-12-31
Current period

USD 10.11 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

10106000 − 8031000 = 2075000 USD

8031000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
10106000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Year-over-year change in Capital expenditure: 2075000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 10106000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2744993 Filing: 000119312526103128 Input fundies:CapitalExpenditure: 8031000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2746803 Filing: 000119312526103128
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 3.18 billion 100% of revenue
Operating costs Derived USD 3.1 billion 98% of revenue
Operating income USD 78.53 million 2.5% of revenue
Tax, interest and other Derived USD 56.04 million 1.8% of revenue
Net income USD 22.49 million 0.7% of revenue

Cash

Operating cash flow USD 114.6 million 3.6% of revenue
Capital expenditure USD 10.11 million 0.3% of revenue
Free cash flow Derived USD 104.49 million 3.3% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 118% of revenue.
2017 90%
2018 15%83%
2019 94%
2020 88%
2021 87%
2022 91%
2023 94%
2024 96%
2025 98%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2016-04-01 – 2017-03-31	57427701	67964651 Derived	-10536950	-1567134 Derived	-8969816	-8436639 Derived	Source 2016-04-01 – 2017-03-31: 57427701 USD Inspect Revenue Open source 2016-04-01 – 2017-03-31: -10536950 USD Inspect Operating Income Open source 2016-04-01 – 2017-03-31: -8969816 USD Inspect Net Income Open source 2016-04-01 – 2017-03-31: -8139078 USD Inspect Operating Cash Flow Open source 2016-04-01 – 2017-03-31: 297561 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	356355930	321209963 Derived	35145967	9344125 Derived	25801842	49749153 Derived	Source 2017-01-01 – 2017-12-31: 356355930 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 35145967 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 25801842 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 51833923 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 2084770 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	519908000	431476000 Derived	88432000	77597000 Derived	10835000	24326000 Derived	Source 2018-01-01 – 2018-12-31: 519908000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 88432000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 10835000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 25496000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1170000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	560618000	528198000 Derived	32420000	18304000 Derived	14116000	12631000 Derived	Source 2019-01-01 – 2019-12-31: 560618000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 32420000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 14116000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 13673000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1042000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	687180000	606677000 Derived	80503000	42815000 Derived	37688000	44999000 Derived	Source 2020-01-01 – 2020-12-31: 687180000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 80503000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 37688000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 46163000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1164000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	773915000	675736000 Derived	98179000	29256000 Derived	68923000	51112000 Derived	Source 2021-01-01 – 2021-12-31: 773915000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 98179000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 68923000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 70335000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 19223000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1144163000	1039898000 Derived	104265000	59094000 Derived	45171000	59188000 Derived	Source 2022-01-01 – 2022-12-31: 1144163000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 104265000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 45171000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 82128000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 22940000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1386661000	1302048000 Derived	84613000	23896000 Derived	60717000	39698000 Derived	Source 2023-01-01 – 2023-12-31: 1386661000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: 84613000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 60717000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 68227000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 28529000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2034540000	1945190000 Derived	89350000	46201000 Derived	43149000	44167000 Derived	Source 2024-01-01 – 2024-12-31: 2034540000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 89350000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 43149000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 52198000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 8031000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	3181769000	3103244000 Derived	78525000	56038000 Derived	22487000	104491000 Derived	Source 2025-01-01 – 2025-12-31: 3181769000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 78525000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 22487000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 114597000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 10106000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-03-31	Revenue	57427701	Revenue: 57427701 Open source
20172017-12-31	Revenue	356355930	Revenue: 356355930 Open source
20182018-12-31	Revenue	519908000	Revenue: 519908000 Open source
20192019-12-31	Revenue	560618000	Revenue: 560618000 Open source
20202020-12-31	Revenue	687180000	Revenue: 687180000 Open source
20212021-12-31	Revenue	773915000	Revenue: 773915000 Open source
20222022-12-31	Revenue	1144163000	Revenue: 1144163000 Open source
20232023-12-31	Revenue	1386661000	Revenue: 1386661000 Open source
20242024-12-31	Revenue	2034540000	Revenue: 2034540000 Open source
20252025-12-31	Revenue	3181769000	Revenue: 3181769000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

56.4% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-03-31	Year over year	No prior comparable period	Revenue: 57427701 Open source
20172017-12-31	Year over year	16.5%	Revenue: 356355930 Open source Revenue: 305934915 Open source
20182018-12-31	Year over year	45.9%	Revenue: 519908000 Open source Revenue: 356355930 Open source
20192019-12-31	Year over year	7.8%	Revenue: 560618000 Open source Revenue: 519908000 Open source
20202020-12-31	Year over year	22.6%	Revenue: 687180000 Open source Revenue: 560618000 Open source
20212021-12-31	Year over year	12.6%	Revenue: 773915000 Open source Revenue: 687180000 Open source
20222022-12-31	Year over year	47.8%	Revenue: 1144163000 Open source Revenue: 773915000 Open source
20232023-12-31	Year over year	21.2%	Revenue: 1386661000 Open source Revenue: 1144163000 Open source
20242024-12-31	Year over year	46.7%	Revenue: 2034540000 Open source Revenue: 1386661000 Open source
20252025-12-31	Year over year	56.4%	Revenue: 3181769000 Open source Revenue: 2034540000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 2.5% 2025

Net margin 0.7% 2025

Free cash flow margin 3.3% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-03-31	Operating margin	-18.3%	Operating Income: -10536950 Open source Revenue: 57427701 Open source
20172017-12-31	Operating margin	9.9%	Operating Income: 35145967 Open source Revenue: 356355930 Open source
20182018-12-31	Operating margin	17%	Operating Income: 88432000 Open source Revenue: 519908000 Open source
20192019-12-31	Operating margin	5.8%	Operating Income: 32420000 Open source Revenue: 560618000 Open source
20202020-12-31	Operating margin	11.7%	Operating Income: 80503000 Open source Revenue: 687180000 Open source
20212021-12-31	Operating margin	12.7%	Operating Income: 98179000 Open source Revenue: 773915000 Open source
20222022-12-31	Operating margin	9.1%	Operating Income: 104265000 Open source Revenue: 1144163000 Open source
20232023-12-31	Operating margin	6.1%	Operating Income: 84613000 Open source Revenue: 1386661000 Open source
20242024-12-31	Operating margin	4.4%	Operating Income: 89350000 Open source Revenue: 2034540000 Open source
20252025-12-31	Operating margin	2.5%	Operating Income: 78525000 Open source Revenue: 3181769000 Open source
20172017-03-31	Net margin	-15.6%	Net Income: -8969816 Open source Revenue: 57427701 Open source
20172017-12-31	Net margin	7.2%	Net Income: 25801842 Open source Revenue: 356355930 Open source
20182018-12-31	Net margin	2.1%	Net Income: 10835000 Open source Revenue: 519908000 Open source
20192019-12-31	Net margin	2.5%	Net Income: 14116000 Open source Revenue: 560618000 Open source
20202020-12-31	Net margin	5.5%	Net Income: 37688000 Open source Revenue: 687180000 Open source
20212021-12-31	Net margin	8.9%	Net Income: 68923000 Open source Revenue: 773915000 Open source
20222022-12-31	Net margin	3.9%	Net Income: 45171000 Open source Revenue: 1144163000 Open source
20232023-12-31	Net margin	4.4%	Net Income: 60717000 Open source Revenue: 1386661000 Open source
20242024-12-31	Net margin	2.1%	Net Income: 43149000 Open source Revenue: 2034540000 Open source
20252025-12-31	Net margin	0.7%	Net Income: 22487000 Open source Revenue: 3181769000 Open source
20172017-03-31	Free cash flow margin	-14.7%	Revenue: 57427701 Open source Operating Cash Flow: -8139078 Open source Capital Expenditure: 297561 Open source
20172017-12-31	Free cash flow margin	14%	Revenue: 356355930 Open source Operating Cash Flow: 51833923 Open source Capital Expenditure: 2084770 Open source
20182018-12-31	Free cash flow margin	4.7%	Revenue: 519908000 Open source Operating Cash Flow: 25496000 Open source Capital Expenditure: 1170000 Open source
20192019-12-31	Free cash flow margin	2.3%	Revenue: 560618000 Open source Operating Cash Flow: 13673000 Open source Capital Expenditure: 1042000 Open source
20202020-12-31	Free cash flow margin	6.5%	Revenue: 687180000 Open source Operating Cash Flow: 46163000 Open source Capital Expenditure: 1164000 Open source
20212021-12-31	Free cash flow margin	6.6%	Revenue: 773915000 Open source Operating Cash Flow: 70335000 Open source Capital Expenditure: 19223000 Open source
20222022-12-31	Free cash flow margin	5.2%	Revenue: 1144163000 Open source Operating Cash Flow: 82128000 Open source Capital Expenditure: 22940000 Open source
20232023-12-31	Free cash flow margin	2.9%	Revenue: 1386661000 Open source Operating Cash Flow: 68227000 Open source Capital Expenditure: 28529000 Open source
20242024-12-31	Free cash flow margin	2.2%	Revenue: 2034540000 Open source Operating Cash Flow: 52198000 Open source Capital Expenditure: 8031000 Open source
20252025-12-31	Free cash flow margin	3.3%	Revenue: 3181769000 Open source Operating Cash Flow: 114597000 Open source Capital Expenditure: 10106000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 114.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-03-31	Operating cash flow	-8139078	Operating Cash Flow: -8139078 Open source
20172017-12-31	Operating cash flow	51833923	Operating Cash Flow: 51833923 Open source
20182018-12-31	Operating cash flow	25496000	Operating Cash Flow: 25496000 Open source
20192019-12-31	Operating cash flow	13673000	Operating Cash Flow: 13673000 Open source
20202020-12-31	Operating cash flow	46163000	Operating Cash Flow: 46163000 Open source
20212021-12-31	Operating cash flow	70335000	Operating Cash Flow: 70335000 Open source
20222022-12-31	Operating cash flow	82128000	Operating Cash Flow: 82128000 Open source
20232023-12-31	Operating cash flow	68227000	Operating Cash Flow: 68227000 Open source
20242024-12-31	Operating cash flow	52198000	Operating Cash Flow: 52198000 Open source
20252025-12-31	Operating cash flow	114597000	Operating Cash Flow: 114597000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 104.5M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-03-31	Free cash flow	-8436639	Operating Cash Flow: -8139078 Open source Capital Expenditure: 297561 Open source
20172017-12-31	Free cash flow	49749153	Operating Cash Flow: 51833923 Open source Capital Expenditure: 2084770 Open source
20182018-12-31	Free cash flow	24326000	Operating Cash Flow: 25496000 Open source Capital Expenditure: 1170000 Open source
20192019-12-31	Free cash flow	12631000	Operating Cash Flow: 13673000 Open source Capital Expenditure: 1042000 Open source
20202020-12-31	Free cash flow	44999000	Operating Cash Flow: 46163000 Open source Capital Expenditure: 1164000 Open source
20212021-12-31	Free cash flow	51112000	Operating Cash Flow: 70335000 Open source Capital Expenditure: 19223000 Open source
20222022-12-31	Free cash flow	59188000	Operating Cash Flow: 82128000 Open source Capital Expenditure: 22940000 Open source
20232023-12-31	Free cash flow	39698000	Operating Cash Flow: 68227000 Open source Capital Expenditure: 28529000 Open source
20242024-12-31	Free cash flow	44167000	Operating Cash Flow: 52198000 Open source Capital Expenditure: 8031000 Open source
20252025-12-31	Free cash flow	104491000	Operating Cash Flow: 114597000 Open source Capital Expenditure: 10106000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

74.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-03-31	Liabilities / assets	98.7%	Total Liabilities: 20374189 Open source Total Assets: 20644557 Open source
20172017-12-31	Liabilities / assets	31.5%	Total Liabilities: 154322623 Open source Total Assets: 490635793 Open source
20182018-12-31	Liabilities / assets	20.7%	Total Liabilities: 106337868 Open source Total Assets: 512999049 Open source
20192019-12-31	Liabilities / assets	50.5%	Total Liabilities: 367653000 Open source Total Assets: 728713000 Open source
20202020-12-31	Liabilities / assets	45.5%	Total Liabilities: 372338000 Open source Total Assets: 817486000 Open source
20212021-12-31	Liabilities / assets	41.1%	Total Liabilities: 356719000 Open source Total Assets: 867361000 Open source
20222022-12-31	Liabilities / assets	42.2%	Total Liabilities: 407666000 Open source Total Assets: 966213000 Open source
20232023-12-31	Liabilities / assets	56%	Total Liabilities: 522593000 Open source Total Assets: 933361000 Open source
20242024-12-31	Liabilities / assets	62.1%	Total Liabilities: 840726000 Open source Total Assets: 1354894000 Open source
20252025-12-31	Liabilities / assets	74.8%	Total Liabilities: 1660327000 Open source Total Assets: 2218661000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.4× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-03-31	Current assets / current liabilities	1.03×	Current Assets: 14922250 Open source Current Liabilities: 14543104 Open source
20172017-12-31	Current assets / current liabilities	1.32×	Current Assets: 144159562 Open source Current Liabilities: 109601999 Open source
20182018-12-31	Current assets / current liabilities	2.4×	Current Assets: 172862792 Open source Current Liabilities: 72019647 Open source
20192019-12-31	Current assets / current liabilities	3.12×	Current Assets: 329068000 Open source Current Liabilities: 105424000 Open source
20202020-12-31	Current assets / current liabilities	2.94×	Current Assets: 338577000 Open source Current Liabilities: 114992000 Open source
20212021-12-31	Current assets / current liabilities	3.53×	Current Assets: 404460000 Open source Current Liabilities: 114719000 Open source
20222022-12-31	Current assets / current liabilities	2.88×	Current Assets: 428125000 Open source Current Liabilities: 148610000 Open source
20232023-12-31	Current assets / current liabilities	2.11×	Current Assets: 461507000 Open source Current Liabilities: 218674000 Open source
20242024-12-31	Current assets / current liabilities	1.75×	Current Assets: 638496000 Open source Current Liabilities: 365608000 Open source
20252025-12-31	Current assets / current liabilities	1.4×	Current Assets: 863313000 Open source Current Liabilities: 615273000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-04-01 – 2017-03-31	−USD 8.97 million Exact value Exact value: -8969816 USD 2016-04-01 – 2017-03-31: -8969816 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2017-03-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: -8969816 USD Concept: fundies:NetIncome Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:NetIncome: -8969816 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000114420417034759/ameh-20170331.xml#192374 Filing: 000114420417034759 The citation records this snapshot. The page link may show a newer release later.	−USD 8.14 million Exact value Exact value: -8139078 USD 2016-04-01 – 2017-03-31: -8139078 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2017-03-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: -8139078 USD Concept: fundies:OperatingCashFlow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8139078 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000114420417034759/ameh-20170331.xml#199717 Filing: 000114420417034759 The citation records this snapshot. The page link may show a newer release later.	USD 297,561 Exact value Exact value: 297561 USD 2016-04-01 – 2017-03-31: 297561 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2017-03-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 297561 USD Concept: fundies:CapitalExpenditure Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 297561 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000114420417034759/ameh-20170331.xml#196921 Filing: 000114420417034759 The citation records this snapshot. The page link may show a newer release later.	−USD 8.44 million Calculation and evidence -8139078 − 297561 USD Exact free cash flow: -8436639 USD 2016-04-01 – 2017-03-31: -8139078 USD · Inspect Operating Cash Flow · Source 2016-04-01 – 2017-03-31: 297561 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2017-03-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: -8436639 USD Concept: free-cash-flow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8139078 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000114420417034759/ameh-20170331.xml#199717 Filing: 000114420417034759 Input fundies:CapitalExpenditure: 297561 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000114420417034759/ameh-20170331.xml#196921 Filing: 000114420417034759 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 25.8 million Exact value Exact value: 25801842 USD 2017-01-01 – 2017-12-31: 25801842 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2017-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 25801842 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 25801842 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828020003626/ameh-20191231.xml#686755 Filing: 000162828020003626 The citation records this snapshot. The page link may show a newer release later.	USD 51.83 million Exact value Exact value: 51833923 USD 2017-01-01 – 2017-12-31: 51833923 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2017-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 51833923 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 51833923 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828020003626/ameh-20191231.xml#686125 Filing: 000162828020003626 The citation records this snapshot. The page link may show a newer release later.	USD 2.08 million Exact value Exact value: 2084770 USD 2017-01-01 – 2017-12-31: 2084770 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2017-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 2084770 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2084770 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828020003626/ameh-20191231.xml#714145 Filing: 000162828020003626 The citation records this snapshot. The page link may show a newer release later.	USD 49.75 million Calculation and evidence 51833923 − 2084770 USD Exact free cash flow: 49749153 USD 2017-01-01 – 2017-12-31: 51833923 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2084770 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2017-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 49749153 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 51833923 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828020003626/ameh-20191231.xml#686125 Filing: 000162828020003626 Input fundies:CapitalExpenditure: 2084770 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828020003626/ameh-20191231.xml#714145 Filing: 000162828020003626 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 10.84 million Exact value Exact value: 10835000 USD 2018-01-01 – 2018-12-31: 10835000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2018-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 10835000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10835000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828021004679/ameh-20201231.htm#1347986 Filing: 000162828021004679 The citation records this snapshot. The page link may show a newer release later.	USD 25.5 million Exact value Exact value: 25496000 USD 2018-01-01 – 2018-12-31: 25496000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2018-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 25496000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25496000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828021004679/ameh-20201231.htm#1639077 Filing: 000162828021004679 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1170000 USD 2018-01-01 – 2018-12-31: 1170000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2018-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 1170000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1170000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828021004679/ameh-20201231.htm#1676391 Filing: 000162828021004679 The citation records this snapshot. The page link may show a newer release later.	USD 24.33 million Calculation and evidence 25496000 − 1170000 USD Exact free cash flow: 24326000 USD 2018-01-01 – 2018-12-31: 25496000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1170000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2018-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 24326000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25496000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828021004679/ameh-20201231.htm#1639077 Filing: 000162828021004679 Input fundies:CapitalExpenditure: 1170000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828021004679/ameh-20201231.htm#1676391 Filing: 000162828021004679 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 14.12 million Exact value Exact value: 14116000 USD 2019-01-01 – 2019-12-31: 14116000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2019-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 14116000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 14116000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828022004291/ameh-20211231.htm#1310522 Filing: 000162828022004291 The citation records this snapshot. The page link may show a newer release later.	USD 13.67 million Exact value Exact value: 13673000 USD 2019-01-01 – 2019-12-31: 13673000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2019-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 13673000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 13673000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828022004291/ameh-20211231.htm#1624857 Filing: 000162828022004291 The citation records this snapshot. The page link may show a newer release later.	USD 1.04 million Exact value Exact value: 1042000 USD 2019-01-01 – 2019-12-31: 1042000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2019-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 1042000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1042000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828022004291/ameh-20211231.htm#1663183 Filing: 000162828022004291 The citation records this snapshot. The page link may show a newer release later.	USD 12.63 million Calculation and evidence 13673000 − 1042000 USD Exact free cash flow: 12631000 USD 2019-01-01 – 2019-12-31: 13673000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1042000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2019-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 12631000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13673000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828022004291/ameh-20211231.htm#1624857 Filing: 000162828022004291 Input fundies:CapitalExpenditure: 1042000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828022004291/ameh-20211231.htm#1663183 Filing: 000162828022004291 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 37.69 million Exact value Exact value: 37688000 USD 2020-01-01 – 2020-12-31: 37688000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2020-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 37688000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 37688000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028675/ameh-20221231.htm#2002704 Filing: 000162828023028675 The citation records this snapshot. The page link may show a newer release later.	USD 46.16 million Exact value Exact value: 46163000 USD 2020-01-01 – 2020-12-31: 46163000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2020-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 46163000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 46163000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028675/ameh-20221231.htm#1649216 Filing: 000162828023028675 The citation records this snapshot. The page link may show a newer release later.	USD 1.16 million Exact value Exact value: 1164000 USD 2020-01-01 – 2020-12-31: 1164000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2020-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 1164000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1164000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028675/ameh-20221231.htm#1665555 Filing: 000162828023028675 The citation records this snapshot. The page link may show a newer release later.	USD 45 million Calculation and evidence 46163000 − 1164000 USD Exact free cash flow: 44999000 USD 2020-01-01 – 2020-12-31: 46163000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1164000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2020-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 44999000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 46163000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028675/ameh-20221231.htm#1649216 Filing: 000162828023028675 Input fundies:CapitalExpenditure: 1164000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028675/ameh-20221231.htm#1665555 Filing: 000162828023028675 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 68.92 million Exact value Exact value: 68923000 USD 2021-01-01 – 2021-12-31: 68923000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2021-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 68923000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 68923000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828024008024/asth-20231231.htm#1316663 Filing: 000162828024008024 The citation records this snapshot. The page link may show a newer release later.	USD 70.34 million Exact value Exact value: 70335000 USD 2021-01-01 – 2021-12-31: 70335000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2021-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 70335000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 70335000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828024008024/asth-20231231.htm#1563348 Filing: 000162828024008024 The citation records this snapshot. The page link may show a newer release later.	USD 19.22 million Exact value Exact value: 19223000 USD 2021-01-01 – 2021-12-31: 19223000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2021-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 19223000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19223000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828024008024/asth-20231231.htm#1579233 Filing: 000162828024008024 The citation records this snapshot. The page link may show a newer release later.	USD 51.11 million Calculation and evidence 70335000 − 19223000 USD Exact free cash flow: 51112000 USD 2021-01-01 – 2021-12-31: 70335000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 19223000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2021-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 51112000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 70335000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828024008024/asth-20231231.htm#1563348 Filing: 000162828024008024 Input fundies:CapitalExpenditure: 19223000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000162828024008024/asth-20231231.htm#1579233 Filing: 000162828024008024 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 45.17 million Exact value Exact value: 45171000 USD 2022-01-01 – 2022-12-31: 45171000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2022-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 45171000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 45171000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-20241231.htm#2076805 Filing: 000095017025039122 The citation records this snapshot. The page link may show a newer release later.	USD 82.13 million Exact value Exact value: 82128000 USD 2022-01-01 – 2022-12-31: 82128000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2022-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 82128000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 82128000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-20241231.htm#2756097 Filing: 000095017025039122 The citation records this snapshot. The page link may show a newer release later.	USD 22.94 million Exact value Exact value: 22940000 USD 2022-01-01 – 2022-12-31: 22940000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2022-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 22940000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22940000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-20241231.htm#2795785 Filing: 000095017025039122 The citation records this snapshot. The page link may show a newer release later.	USD 59.19 million Calculation and evidence 82128000 − 22940000 USD Exact free cash flow: 59188000 USD 2022-01-01 – 2022-12-31: 82128000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 22940000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2022-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 59188000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 82128000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-20241231.htm#2756097 Filing: 000095017025039122 Input fundies:CapitalExpenditure: 22940000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-20241231.htm#2795785 Filing: 000095017025039122 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	USD 60.72 million Exact value Exact value: 60717000 USD 2023-01-01 – 2023-12-31: 60717000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2023-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 60717000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: 60717000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2061669 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 68.23 million Exact value Exact value: 68227000 USD 2023-01-01 – 2023-12-31: 68227000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2023-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 68227000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 68227000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2711576 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 28.53 million Exact value Exact value: 28529000 USD 2023-01-01 – 2023-12-31: 28529000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2023-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 28529000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28529000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2748612 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 39.7 million Calculation and evidence 68227000 − 28529000 USD Exact free cash flow: 39698000 USD 2023-01-01 – 2023-12-31: 68227000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 28529000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2023-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 39698000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 68227000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2711576 Filing: 000119312526103128 Input fundies:CapitalExpenditure: 28529000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2748612 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 43.15 million Exact value Exact value: 43149000 USD 2024-01-01 – 2024-12-31: 43149000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2024-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 43149000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 43149000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2059840 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 52.2 million Exact value Exact value: 52198000 USD 2024-01-01 – 2024-12-31: 52198000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2024-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 52198000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 52198000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2709735 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 8.03 million Exact value Exact value: 8031000 USD 2024-01-01 – 2024-12-31: 8031000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2024-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 8031000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8031000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2746803 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 44.17 million Calculation and evidence 52198000 − 8031000 USD Exact free cash flow: 44167000 USD 2024-01-01 – 2024-12-31: 52198000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 8031000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2024-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 44167000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 52198000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2709735 Filing: 000119312526103128 Input fundies:CapitalExpenditure: 8031000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2746803 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 22.49 million Exact value Exact value: 22487000 USD 2025-01-01 – 2025-12-31: 22487000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Net Income: 22487000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 22487000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2058011 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 114.6 million Exact value Exact value: 114597000 USD 2025-01-01 – 2025-12-31: 114597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Operating Cash Flow: 114597000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 114597000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2707893 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 10.11 million Exact value Exact value: 10106000 USD 2025-01-01 – 2025-12-31: 10106000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Capital Expenditure: 10106000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10106000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2744993 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.	USD 104.49 million Calculation and evidence 114597000 − 10106000 USD Exact free cash flow: 104491000 USD 2025-01-01 – 2025-12-31: 114597000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 10106000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Apollo Medical Holdings, Inc. · 2025-12-31 Apollo Medical Holdings, Inc. (edgar:1083446) Free cash flow: 104491000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:01:48Z Snapshot: 066797db93364b2ec958f0e2d80a56c38a6dfe9e1e5061496893bfb645f11d18 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1083446?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 114597000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2707893 Filing: 000119312526103128 Input fundies:CapitalExpenditure: 10106000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1083446/000119312526103128/asth-20251231.htm#2744993 Filing: 000119312526103128 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

232 filings · 7,058 latest values · 7,058 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001083446, 1083446, AMEH, ASTH, edgar:1083446

Also known as APOLLO MEDICAL HOLDINGS, INC., ASTRANA HEALTH, INC., Apollo Medical Holdings, Inc., Astrana Health, Inc., SICLONE INDUSTRIES INC

Apollo Medical Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation